Clinical Trial Update: A Study of Darbepoetin Alfa in Patients With Myelodysplastic Syndrome (MDS) [Phase 1, Phase 2]

View source ↗

Summary

This update notes the completion of a Phase 1/2 trial of darbepoetin alfa in patients with myelodysplastic syndromes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndromes

Drugs mentioned

• ARANESP (DARBEPOETIN ALFA)

Snippet

Sponsor: Peter L Greenberg | Conditions: Blood Cancer, Myelodysplastic Syndromes | Phase 1, Phase 2 | Status: COMPLETED